three patients with hodgkin disease , eight with non-hodgkin lymphoma , and one with chronic lymphocytic leukemia refractory to conventional combination chemotherapy were treated for remission induction with a new kinetically designed four-drug combination consisting of bleomycin , vincristine , adriamycin , and prednisone and given the acronym `` '' boap . '' ''
C0024305
non-hodgkin lymphoma
C0042679
vincristine